deferiprone has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adlard, PA; Ayton, S; Bush, AI; Duce, JA; Finkelstein, DI; Lei, P; Sedjahtera, A; Wong, BX | 1 |
Aguirre, P; Carrasco, CM; Cassels, BK; García-Beltrán, O; González-Billault, C; Mena, NP; Méndez-Gálvez, C; Morales, RA; Muñoz, Y; Núñez, MT; Pérez-Henríquez, P | 1 |
2 other study(ies) available for deferiprone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Animals; Case-Control Studies; Ceruloplasmin; Deferiprone; Disease Models, Animal; Dopamine Agents; Female; Humans; Iron Chelating Agents; Male; Mice; Mice, Knockout; Parkinson Disease; Pyridones; Substantia Nigra | 2013 |
Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,2'-Dipyridyl; Animals; Antioxidants; Deferiprone; Deferoxamine; Dopaminergic Neurons; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Hydroxyquinolines; Iron Chelating Agents; Lipid Peroxidation; Male; Mesencephalon; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Fibers; Neurites; Neuroprotective Agents; Primary Cell Culture; Pyridones; Rats; Rats, Sprague-Dawley; Synaptophysin; Tyrosine 3-Monooxygenase | 2015 |